Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
NEW YORK, April 18, 2022 /PRNewswire/ -- Today, CLEAR (NYSE:YOU), the secure identity company, announced that as of April 15, 2022 it has reached 12 million total cumulative enrollments across its
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.